TY - CHAP
T1 - Advances in exosome analysis
AU - Pallares-Rusiñol, Arnau
AU - Bernuz, Mireia
AU - Moura, Silio Lima
AU - Fernández-Senac, Carolina
AU - Rossi, Rosanna
AU - Martí, Mercè
AU - Pividori, María Isabel
N1 - Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - There is growing demand for novel biomarkers that detect early stage disease as well as monitor clinical management and therapeutic strategies. Exosome analysis could provide the next advance in attaining that goal. Exosomes are membrane encapsulated biologic nanometric-sized particles of endocytic origin which are released by all cell types. Unfortunately, exosomes are exceptionally challenging to characterize with current technologies. Exosomes are between 30 and 200 nm in diameter, a size that makes them out of the sensitivity range to most cell-oriented sorting or analysis platforms, i.e., traditional flow cytometers. The most common methods for targeting exosomes to date typically involve purification followed by the characterization and the specific determination of their cargo. The whole procedure is time consuming, requiring thus skilled personnel as well as laboratory facilities and benchtop instrumentation. The most relevant methodology for exosome isolation, characterization and quantification is addressed in this chapter, including the most up-to-date approaches to explore the potential usefulness of exosomes as biomarkers in liquid biopsies and in advanced nanomedicine.
AB - There is growing demand for novel biomarkers that detect early stage disease as well as monitor clinical management and therapeutic strategies. Exosome analysis could provide the next advance in attaining that goal. Exosomes are membrane encapsulated biologic nanometric-sized particles of endocytic origin which are released by all cell types. Unfortunately, exosomes are exceptionally challenging to characterize with current technologies. Exosomes are between 30 and 200 nm in diameter, a size that makes them out of the sensitivity range to most cell-oriented sorting or analysis platforms, i.e., traditional flow cytometers. The most common methods for targeting exosomes to date typically involve purification followed by the characterization and the specific determination of their cargo. The whole procedure is time consuming, requiring thus skilled personnel as well as laboratory facilities and benchtop instrumentation. The most relevant methodology for exosome isolation, characterization and quantification is addressed in this chapter, including the most up-to-date approaches to explore the potential usefulness of exosomes as biomarkers in liquid biopsies and in advanced nanomedicine.
KW - ELISA
KW - Exosomes
KW - Flow cytometry
KW - Immunomagnetic separation
KW - Liquid biopsy
KW - NTA
KW - Nanovesicles
KW - PCR
KW - Solid-phase preconcentration
KW - Liquid Biopsy
KW - Humans
KW - Exosomes/metabolism
KW - Biomarkers/metabolism
KW - Lung-cancer
KW - Tumor-derived exosomes
KW - Extracellular vesicles
KW - Cancer cell-lines
KW - Intercellular-adhesion molecule-1
KW - Messenger-rnas
KW - Atomic-force microscopy
KW - Colorectal-cancer
KW - Prostate-cancer
KW - Gastric-cancer
UR - http://www.scopus.com/inward/record.url?scp=85144550347&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/2401f992-ac23-3dfc-b2c4-0581511dee8f/
U2 - 10.1016/bs.acc.2022.09.002
DO - 10.1016/bs.acc.2022.09.002
M3 - Chapter
C2 - 36642486
SN - 9780443192845
VL - 112
T3 - Advances in clinical chemistry
SP - 69
EP - 117
BT - Advances in Clinical Chemistry
A2 - Makowski, Gregory S.
A2 - Makowski, Gregory S.
ER -